Diligence memo · auto-generated · as of July 2, 2026
Immune Co.
Immune Co. looks under-valued against its niche peers and is quiet on financing cadence.
Businessfiled
Immune Co. operates in Other Technology, based in BOSTON.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Immune Co. has raised $7.4M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $6.4M on 2025-01-17.
Most recent recorded round closed around 2025-01-27.
Valuation (modeled)modeled
Provath models Immune Co. at approximately $4.4M (range $1.3M–$8.3M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.21× the median modeled value of Series A Other Technology companies in 2025–2027 (569 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 0 months.
Last raise 17 mo ago; this sector typically re-raises about every 13 months.
Slightly overdue versus sector cadence.
The last round was 6.4× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 67% of Other Technology peers (21302 compared).
Modeled value ranks above 12% of those peers.
Closest niche peers: Beaconcure Inc., Edera, Inc. / DE, Clarify Inc./DE, Palla Financial Inc., eWellbore, LLC.
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.